Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Cyclopentanohydrophenanthrene ring system doai
Patent
1991-12-12
1993-11-16
Waddell, Frederick E.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Cyclopentanohydrophenanthrene ring system doai
514170, 514179, 514843, A61K 3156
Patent
active
052624080
ABSTRACT:
Disclosed is a contraceptive regimen, and method of using the regimen, comprising 24 daily sequential dosage units of: a first phase comprising about 7 to 9 separate first dosage units containing a progestogen at a daily dosage equivalent in progestogenic activity to 100 desogestrel and an estrogen at a daily dosage equivalent in estrogenic activity to 25 .mu.g ethinyl estradiol ("EE"). A second phase of 7 to 9 second dosage units, each of the second dosage units containing a progestogen equivalent to 125 .mu.g desogestrel and an estrogen equivalent lent to 20 .mu.g EE. A third phase of 7 to 9 third dosage units, each unit containing a progestogen equivalent to 50 .mu.g desogestrel and an estrogen equivalent to 20 .mu.g EE. The kit generally has 28 daily dosage units wherein four of the daily dosage units contain no contraceptive steroid, or, alternatively, have only 24 dosage units with a four day "pill-free" period. The fourth phase may also be four dosage units containing a progestogen equivalent to 25-35 .mu.g desogestrel.
REFERENCES:
patent: 4378356 (1983-03-01), de Jager et al.
patent: 4544554 (1985-10-01), Pasquale
patent: 4616006 (1986-10-01), Pasquale
patent: 4628051 (1986-12-01), Pasquale
CA 114:88652v, De Jager, 1990.
Akzo N.V.
Blackstone William M.
Jordan Kimberly R.
Waddell Frederick E.
LandOfFree
Low estrogen oral contraceptives does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Low estrogen oral contraceptives, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Low estrogen oral contraceptives will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-22673